This appeal was not successful at this stage
The AAO dismissed the appeal because the petitioner failed to satisfy at least three of the required evidentiary criteria under 8 C.F.R. § 204.5(h)(3). Although the AAO corrected several errors in the Director's analysis, it found that none of the six criteria claimed by the petitioner were met.
3 more criteria would trigger a full merits review.
The petitioner, a pharmaceutical production manager specializing in microbiology, sought EB-1A classification but the AAO dismissed his appeal after finding he met zero of the required three evidentiary criteria. The AAO corrected multiple Director errors — including an improper material-change finding, a wrongly granted judging criterion, and an overly narrow field definition — but these corrections did not help the petitioner. His awards lacked documentation of criteria and recognition; his only newspaper article had a deficient translation; his WHO and USP comment submissions were open public processes, not invited judging; and while he demonstrated a critical role at his employer's production facility, he could not show that facility had a distinguished reputation. The case illustrates that correcting a Director's errors on appeal does not guarantee success if the underlying evidence is substantively insufficient.
What worked: Petitioner successfully argued that his field is microbiology broadly, not merely microbiology management, and the AAO agreed there was no material change. The AAO also acknowledged he played a critical role at his employer's production facility and a leading role within the microbiology department. His employer's status as a pharmaceutical company and the supervisor's letter were credited for those specific findings.
What failed: No awards were documented with sufficient evidence of criteria, competition level, or national/international field recognition. The sole newspaper article could not be weighed due to a non-compliant translation and missing author name. WHO and USP public consultation submissions were found to be open public comment processes, not invited judging. No evidence of the employer's distinguished reputation in the field was submitted independently of the petitioner's own certificates.
Takeaway: For pharmaceutical or science professionals, petitioners must provide objective third-party documentation for every element of each criterion — for awards, this means competition rules, jury composition, and evidence of field-wide recognition; for judging roles, personal invitation letters rather than public-call responses; and for translation of foreign-language evidence, strict compliance with 8 C.F.R. § 103.2(b)(3) is mandatory. A leading or critical role claim also requires independent evidence of the organization's distinguished reputation beyond internal letters.
Cases like this are frequently used by attorneys when responding to RFEs or building initial petitions. The evidence patterns that worked (or failed) here directly reflect what USCIS officers look for when evaluating EB-1A criteria.
● Evidence that moved the needle
- Petitioner successfully argued that his field is microbiology broadly, not merely microbiology management, and the AAO agreed there was no material change
- The AAO also acknowledged he played a critical role at his employer's production facility and a leading role within the microbiology department
- His employer's status as a pharmaceutical company and the supervisor's letter were credited for those specific findings.
● Evidence that wasn't enough alone
- No awards were documented with sufficient evidence of criteria, competition level, or national/international field recognition
- The sole newspaper article could not be weighed due to a non-compliant translation and missing author name
- WHO and USP public consultation submissions were found to be open public comment processes, not invited judging
- No evidence of the employer's distinguished reputation in the field was submitted independently of the petitioner's own certificates.
Criterion-by-criterion breakdown
Lesser nationally or internationally recognized prizes or awards
Not metThird-prize conference certificate lacked context on criteria and competition; 'Eminent Prudent India' award lacked documentation; 'Certificate of Excellence' rewarded equipment installation project, not excellence in microbiology; other certificates from multinational employers not shown to be nationally/internationally recognized in the field.
Published material about the person
Not metA single paragraph in Indian newspaper Dainik Jagran (2012) was about the petitioner and his work, but the English translation did not comply with 8 C.F.R. § 103.2(b)(3) (translator failed to certify completeness or competence), and the author's name was absent. A post-filing article was excluded. AAO partially disagreed with Director on the article's subject matter and the newspaper's status as major medium, but still found the criterion unmet due to translation deficiencies.
Judging the work of others
Reversed in their favorDirector had found this criterion met based on WHO public consultation comments and USP Pharmacopeial Forum comments. AAO reversed, finding these were voluntary responses to public comment calls, not evidence of being personally invited or selected to judge the work of others.
Authorship of scholarly articles
Not metPetitioner's participation in WHO public consultations did not constitute authorship or editorship of the WHO reports. Keynote speaker evidence did not show authorship of a scholarly article in qualifying media. Argument about keynote speech was waived on appeal.
Leading or critical role for distinguished organizations
Not metPetitioner showed a leading role for the microbiology department and a critical role for his employer's pharmaceutical production facility (including first U.S. installation of colony counter automation equipment), but failed to establish that the department or facility has a distinguished reputation in the field. Evidence of 'state of the art' lab from colleagues insufficient; no independent awards or recognition for the employer were documented.
Employer letter from SVPO confirming petitioner's critical role in ensuring safety and quality of injectable pharmaceuticals and leading the first U.S. installation of colony counter automation equipment.
Organizational chart showing petitioner as senior microbiology manager with 12 direct reports, establishing a leading role within the microbiology department.
Dainik Jagran newspaper evidence (circulation/readership documents) sufficient to verify its status as a major medium in India — though the article itself was given no weight due to translation deficiency.
Employer letter documenting recent promotion and pay raise, establishing intent to continue working in field.
Third-prize conference certificate (2008) — no documentation of award criteria, number of competitors, or basis for excellence finding.
'Eminent Prudent India' award from unnamed organization — no documentation of criteria, competition, or national/international recognition.
'Certificate of Excellence' from equipment company — rewarded dedication to purchasing/installing equipment, not excellence in microbiology.
Employer appreciation certificates — not shown to be nationally or internationally recognized beyond the issuing organizations.
WHO public consultation comment submissions — open public comment process, not personal invitation to judge; acknowledgment in final WHO reports did not establish judging role.
USP Pharmacopeial Forum comment — publicly open review process, not invitation to judge.
Dainik Jagran article (2012) — translation not certified as complete or competent; author name missing; accorded no weight.
Post-filing published article — excluded as not filed contemporaneously.
Expert opinion letter characterizing petitioner as having 'introduced' the colony counter technology — found to be a distortion of the underlying record.
Colleague letters calling microbiology laboratory 'state of the art' — insufficient to establish distinguished reputation of the department, facility, or employer.
Director improperly found a material change to the petition when petitioner clarified his field as 'microbiology' rather than 'microbiology management' — AAO found no material change and withdrew this conclusion.
Director improperly limited evidentiary consideration to the narrower field of microbiology management rather than the broader field of microbiology.
Director incorrectly found the judging criterion (criterion iv) was met based on public consultation comments to WHO and USP that were open to the general public, not evidence of being personally selected as a judge.
Director mischaracterized the petitioner's WHO public consultation role as 'editing,' which she then used to partially credit a scholarly articles claim.
Director incorrectly found that the Dainik Jagran article was not about the petitioner's work in his field and incorrectly assessed it as not a major medium (though this did not change the outcome due to translation deficiencies).
Director's statement that petitioner's role 'may have been leading or critical' was partially withdrawn as the evidence did show a leading role in the microbiology department and a critical role for the production facility.
Completed
I-140 filed
Pharmaceutical production manager specializing in microbiology and sterility in pharmaceutical manufacturing
Completed
Director — Denied
Initial decision: Denied.
Completed
Appeal to the AAO
Petitioner appealed to the Administrative Appeals Office for de novo review.
2024-08-12
AAO decision — Dismissed
The AAO dismissed the appeal because the petitioner failed to satisfy at least three of the required evidentiary criteria under 8 C.F.R. § 204.5(h)(3). Although the AAO corrected several errors in the Director's analysis, it found that none of the six criteria claimed by the petitioner were met.
If you're appealing a similar decision, I-290B must be filed within 30 days of personal service of the denial, or 33 days if mailed.
Find this useful? A coffee helps keep Case Reviewer free and ad-free.
Buy me a coffee